Latest return on equity
C4 Therapeutics Return on equity
C4 Therapeutics (CCCC) return on equity with its verified observation date.
Direct answer
C4 Therapeutics's return on equity is -48.14%.
The verified market snapshot reports -48.14%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked August 20, 2026.
Get free C4 Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -48.14%
Explore related company data
View C4 Therapeutics's market capitalizationView C4 Therapeutics's price-to-book ratioView C4 Therapeutics's 52-week price rangeView C4 Therapeutics's revenue growthView C4 Therapeutics's profit marginView C4 Therapeutics's debt-to-equity ratioView all C4 Therapeutics key metricsReturn to C4 Therapeutics profile